Close Menu

NEW YORK (GenomeWeb) – VolitionRx announced today that it received CE marking for its blood-based NuQ Colorectal Cancer Screening Triage Test, clearing it for commercialization in the European Union.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.